Stigma of Mental Illness in China: Extending the SGC-MHS

中国精神疾病的耻辱:扩展 SGC-MHS

基本信息

  • 批准号:
    8208154
  • 负责人:
  • 金额:
    $ 21.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-04-09 至 2014-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by investigator): According to the U.S. Surgeon General and the World Health Organization (WHO), the stigma attached to mental illness (MI) stands as one of the most critical barriers to recognition, treatment and recovery. Under a special program of the Fogarty International Center and with additional support from the National Institute of Mental Health and the Office of Behavioral and Social Science Research, the Stigma in Global Context - Mental Health Study (SGC-MHS) was mounted to understand the extent to which MI is understood and stigmatized across countries. Despite the inclusion of a wide range of countries, China stands as a notable absence in the SGC-MHS data set. This application is designed to fill that gap by combining substantive expertise on China and its unique sampling challenges with the experience of SGC-MHS researchers. This application proposes to : 1) Estimate the nature, level and individual level correlates of stigma in China using a tailored version of the SGC-MH Study instrument; 2) Use the survey data collected by the Chinese module of the SGC-MHS to test hypotheses concerning the influences of barriers, particularly stigma, to the endorsement of medical and mental health services; 3) Integrate the data from the Chinese module of the SGC-MHS into the larger 16 nation study to examine the causes and correlates of stigma. Towards these ends, data will be collected from a nationally representative sample of the Chinese population (N= 5,250) in face-to-face interviews using a tailored version of the SGCMHS instrument. Adding China to the SGC-MHS will improve understanding of the underlying roots of stigma, sharpen estimates of the global burden of stigma, and provide a critical, scientific base for stigma reduction in China and elsewhere. PUBLIC HEALTH RELEVANCE: With one-fifth of the world's population, China accounts for a sizable share of the global burden of disease, including mental illness. Existing research indicates that stigma shapes both individual (e.g., low service use, prejudice, discrimination) and system problems (e.g., inadequate treatment resources). Examining both the roots and the potential consequences of stigmatizing attitudes, beliefs, and behavioral predispositions in China would significantly improve scientific understanding, the development of interventions and the policy implications of data provided by the existing cross-national collaboration in the SGC-MHS.
描述(由研究者提供):根据美国卫生局局长和世界卫生组织(WHO)的说法,精神疾病(MI)的耻辱是识别,治疗和康复的最关键障碍之一。根据福格蒂国际中心的一项特别计划,并在美国国家心理健康研究所和行为与社会科学研究办公室的额外支持下,开展了全球背景下的耻辱-心理健康研究(SGC-MHS),以了解MI的程度。各国对MI的理解和污名化。尽管纳入了广泛的国家,但中国在SGC-MHS数据集中明显缺席。该申请旨在通过将对中国的实质性专业知识及其独特的采样挑战与SGC-MHS研究人员的经验相结合来填补这一空白。本申请建议:1)使用SGC-MH研究工具的定制版本,估计中国污名的性质、水平和个体水平的相关性; 2)使用SGC-MHS中国模块收集的调查数据,检验关于障碍,特别是污名,对医疗和精神卫生服务认可的影响的假设; 3)将SGC-MHS中国模块的数据整合到更大的16国研究中,以检查污名的原因和相关因素。为此,将使用定制版SGCMHS工具,通过面对面访谈从中国人群的全国代表性样本(N= 5,250)中收集数据。将中国加入SGC-MHS将有助于加深对污名根源的理解,提高对全球污名负担的估计,并为中国和其他地区减少污名提供重要的科学基础。 公共卫生关系:中国人口占世界人口的五分之一,在全球疾病负担中占相当大的份额,包括精神疾病。现有的研究表明,污名塑造了个体(例如,服务使用率低、偏见、歧视)和系统问题(例如,治疗资源不足)。研究中国污名化态度、信念和行为倾向的根源和潜在后果,将显著改善科学理解、干预措施的制定以及SGC-MHS现有跨国合作提供的数据的政策含义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bernice A. Pescosolido其他文献

Cross‐Cultural Aspects of the Stigma of Mental Illness
精神疾病耻辱的跨文化方面
  • DOI:
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Bernice A. Pescosolido;S. Ólafsdóttir;Jack K. Martin;J. Long
  • 通讯作者:
    J. Long

Bernice A. Pescosolido的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bernice A. Pescosolido', 18)}}的其他基金

Modeling the Social Environmental Influences and Mechanisms of Suicide
社会环境影响和自杀机制建模
  • 批准号:
    8532043
  • 财政年份:
    2012
  • 资助金额:
    $ 21.76万
  • 项目类别:
Modeling the Social Environmental Influences and Mechanisms of Suicide
社会环境影响和自杀机制建模
  • 批准号:
    8210165
  • 财政年份:
    2012
  • 资助金额:
    $ 21.76万
  • 项目类别:
Modeling the Social Environmental Influences and Mechanisms of Suicide
社会环境影响和自杀机制建模
  • 批准号:
    8692021
  • 财政年份:
    2012
  • 资助金额:
    $ 21.76万
  • 项目类别:
Career Enhancement for Epigenetic Research on Substance Abuse and Comorbidities
药物滥用和合并症表观遗传学研究的职业提升
  • 批准号:
    8033447
  • 财政年份:
    2010
  • 资助金额:
    $ 21.76万
  • 项目类别:
Stigma of Mental Illness in China: Extending the SGC-MHS
中国精神疾病的耻辱:扩展 SGC-MHS
  • 批准号:
    7787571
  • 财政年份:
    2010
  • 资助金额:
    $ 21.76万
  • 项目类别:
Stigma of Mental Illness in China: Extending the SGC-MHS
中国精神疾病的耻辱:扩展 SGC-MHS
  • 批准号:
    8059663
  • 财政年份:
    2010
  • 资助金额:
    $ 21.76万
  • 项目类别:
Assessing Change in Mental Illness Stigma Over A Decade
评估十年来精神疾病耻辱的变化
  • 批准号:
    7100261
  • 财政年份:
    2005
  • 资助金额:
    $ 21.76万
  • 项目类别:
Assessing Change in Mental Illness Stigma Over A Decade
评估十年来精神疾病耻辱的变化
  • 批准号:
    6964190
  • 财政年份:
    2005
  • 资助金额:
    $ 21.76万
  • 项目类别:
Social Network & Media Effects on Mental Illness Stigma
社交网络
  • 批准号:
    6926273
  • 财政年份:
    2004
  • 资助金额:
    $ 21.76万
  • 项目类别:
Social Network & Media Effects on Mental Illness Stigma
社交网络
  • 批准号:
    7168074
  • 财政年份:
    2004
  • 资助金额:
    $ 21.76万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 21.76万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 21.76万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 21.76万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 21.76万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 21.76万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 21.76万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 21.76万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 21.76万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 21.76万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 21.76万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了